
1. nihon rinsho. 2008 oct;66(10):2008-12.

[alzheimer vaccine].

[article japanese]

tabira t(1).

author information: 
(1)national institute longevity sciences, ncgg.

autopsy cases received abeta vaccine showed clearance senile plaques, 
and beneficial effect shown patients high antibody titers to
amyloid plaques. thus, vaccination widely accepted promising therapy for
alzheimer disease. since active immunization induced autoimmune-like
meningoencephalitis, pharmaceutical companies interested passive
immunization using monoclonal antibodies abeta. however, due immunization
burden economical issues, safe active immunization still attractive. we
developed oral nasal abeta vaccine using viral vectors abeta cdna a
signal peptide. vaccine reduced amyloid burden improved cognitive
functions mice. believe vaccine useful prevention treatment
of alzheimer disease.


pmid: 18939505  [indexed medline]

